Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...
President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...
Clinicians should not neglect proteinuria testing in adults younger than age 40 years to identify those at high risk for sudden cardiac arrest.
Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...
Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...
While Stephen Lambert flew an L-39 Albatross in May of 2024, lifelong friend Greg Scohy was in the backseat enjoying the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results